Saccharomyces boulardii Australia

About Yomogi
Yomogi® Australia’s only strain of Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 – The original strain first isolated by Henri Boulard.

Natural therapy Imports is an Australian company responsible for the supply and distribution of Yomogi® in Australia and New Zealand.

Where to find Yomogi?
Yomogi® – Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 is available in 20 & 50 capsule packs from selected pharmacies and medical/naturopathic dispensaries.

Now also available online from Chemist Warehouse, Natural Chemist and Superpharmacy

20 Capsule Packs RRP $15.00 50 Capsule Packs RRP $29.00

FAQ’s

What is Yomogi®?...and what is it used for?

Yomogi® is a probiotic that comprises as its active substance 250 mg of lyophilized yeast cells that at batch release contains a minimum of 2.5 billion CFU (colony forming units) of a viable non-pathogenic cells of the yeast strain Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926. Saccharomyces boulardii is indicated for the treatment of diarrhoea, often a symptom of gastrointestinal disorders. Saccharomyces boulardii is able to help and support a healthy microbial environment.

Is Saccharomyces boulardii the same as Saccharomyces cerevisiae?

No, Saccharomyces boulardii is not Saccharomyces cerevisiae. Saccharomyces boulardii is a wild, tropical yeast while Saccharomyces cerevisiae, is commonly known as brewer’s or baker’s yeast. Whilst closely related to Saccharomyces cerevisiae, the Saccharomyces boulardii in Yomogi® is officially classified as Saccharomyces cerevisiae var boulardii Hansen CBS 5926. Often referred to in the clinical setting as Saccharomyces boulardii or SB and SB Probiotic. The two strains have distinct and different genetic makeup and enzyme profiles. Saccharomyces boulardii does not make a certain type of reproductive spore called an ascospore and does not use the sugar galactose. Able to grow at very high temperatures (37°C) and resistant to acid. Only Saccharomyces boulardii has proven gastrointestinal beneficial properties and effects.

Does Saccharomyces boulardii colonise the intestinal tract?

Saccharomyces boulardii does not colonise the human intestinal tract. It is a transient yeast that passes through the intestines after ingestion. S. boulardii does not attach to the mucosal cells lining the intestinal lumen, but exerts its beneficial effects on the host as it moves through the gastrointestinal tract.

Is Saccharomyces boulardii the same as the yeast that causes yeast infections or overgrowth?

No, Saccharomyces boulardii is completely unrelated to Candida albicans and other Candida species that cause disease and overgrowth in the gastrointestinal and genitourinary tracts. Unlike Candida species that decrease the acidity of the gastrointestinal mucosal environment, ultimately making the intestinal mucosal membrane susceptible to invasion by potentially harmful bacteria and yeast. Saccharomyces boulardii exerts the opposite effect producing lactic and other acids known to inhibit potentially harmful Candida yeast species. Animal studies have shown that Saccharomyces boulardii plays a role in preventing the Candida yeast from reproducing in the gut..

Can Yomogi® be taken together with antibiotics

Yomogi® can be taken in conjunction with antibiotics. Unaffected by antibiotics Yomogi® may help maintain and support the gut flora during this time.

Does Yomogi® require refrigeration and is it free from, gluten, wheat or dairy products?

Yomogi® does not contain gluten or wheat products. It does however contain Lactose – 28.75mg.

Most medications containing lactose monohydrate do not have enough lactose present to affect people who are lactose intolerant, namely, those whose digestive systems do not possess the enzymes needed to digest lactose. However lactose-intolerant patients should ask their Doctor or healthcare practitioner whether or not they may safely take certain medications containing lactose.

Yomogi® does not require refrigeration. Yomogi® is lyophilized, a process of freeze drying that ensures the product is heat stable and maintains viable active cells, or colony forming units (CFU).

Does the number of colony forming units (CFU) matter or is it the quality of the strain?

Both are correct. At product release, Yomogi® contains a minimum of 2.5 billion CFU. Ardeypharm of Germany, the manufacturers of Yomogi®, their knowledge and experience in producing high quality probiotic strains is without question as the only E.coli strain probiotic supplier to Australia.

About Yomogi

Where to find Yomogi?

FAQ’s

What is Yomogi®?...and what is it used for?

Is Saccharomyces boulardii the same as Saccharomyces cerevisiae?

Does Saccharomyces boulardii colonise the intestinal tract?

Is Saccharomyces boulardii the same as the yeast that causes yeast infections or overgrowth?

Can Yomogi® be taken together with antibiotics

Does Yomogi® require refrigeration and is it free from, gluten, wheat or dairy products?

Does the number of colony forming units (CFU) matter or is it the quality of the strain?